Compare Dow Inc (DOW) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dow Inc vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Dow Inc trades at $29.46 (market cap $20.59B), while GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and Dow Inc pays the higher dividend (4.91%). Which is the better fit depends on your goals.
| DOW | GEHC | |
|---|---|---|
Market Cap | $20.59B | $31.07B |
Volume | 5,540,746 | 3,443,020 |
Sector | Basic Materials | Health |
52-Week High | $41.87 | $88.16 |
52-Week Low | $20.95 | $59.48 |
Typical Hold Time | 83 Days | — |
Enterprise Value | $36.29B | $39.53B |
Dividend Yield | 4.91% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DOW trades at $28.51, up 1.39% with bearish technical signals despite recent earnings beats. The company faces fundamental challenges with negative net income margin (-3.13%) and ROE (-7.86%), though valuation metrics show moderate P/S (0.5) and P/B (1.3). Cash flow trends show improvement with 2025 net cash flow turning positive at $1.69B after three years of declines. Recent news highlights dividend sustainability concerns in the chemical sector.
Outlook remains cautious with analyst consensus at Hold (55.55%) and $33.80 price target offering 18.6% upside. Key risks include continued margin pressure, declining revenue trends, and high debt levels (debt-to-asset ratio 29.87%). The stock presents value opportunity for patient investors but requires monitoring of operational turnaround and dividend sustainability.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
